Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Serine phosphorylation of insulin receptor substrate-1 (IRS-1) inhibits insulin signal transduction in a variety of cell backgrounds, which might contribute to peripheral insulin resistance. However, because of the large number of potential phosphorylation sites, the mechanism of inhibition has been difficult to determine. One serine residue located near the phosphotyrosine-binding (PTB) domain in IRS-1 (Ser(307) in rat IRS-1 or Ser(312) in human IRS-1) is phosphorylated via several mechanisms, including insulin-stimulated kinases or stress-activated kinases like JNK1. During a yeast tri-hybrid assay, phosphorylation of Ser(307) by JNK1 disrupted the interaction between the catalytic domain of the insulin receptor and the PTB domain of IRS-1. In 32D myeloid progenitor cells, phosphorylation of Ser(307) inhibited insulin stimulation of the phosphatidylinositol 3-kinase and MAPK cascades. These results suggest that inhibition of PTB domain function in IRS-1 by phosphorylation of Ser(307) (Ser(312) in human IRS-1) might be a general mechanism to regulate insulin signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, phosphorylation of these serine residues impedes the normal association of IRS-1 with the insulin receptor, thereby impairing downstream propagation of insulin signaling (16,19).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Dérijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., & Davis, R. J. (1994) · Cell · doi:10.1016/0092-8674(94)90380-8 · Cited by 3,188
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Self-citationStructure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Self-citationAguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Self-citationKuan, C.-Y., Yang, D. D., Roy, D. R. S., Davis, R. J., Rakic, P., & Flavell, R. A. (1999) · Neuron · doi:10.1016/s0896-6273(00)80727-8 · Cited by 894
Protein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854
Role of IRS-2 in insulin and cytokine signalling
Sun, X. J., Wang, L.-M., Zhang, Y., Yenush, L., Myers Jr, M. G., Glasheen, E., Lane, W. S., Pierce, J. H., & White, M. F. (1995) · Nature · doi:10.1038/377173a0 · Cited by 848
Self-citationA Cytoplasmic Inhibitor of the JNK Signal Transduction Pathway
Dickens, M., Rogers, J. S., Cavanagh, J., Raitano, A., Xia, Z., Halpern, J. R., Greenberg, M. E., Sawyers, C. L., & Davis, R. J. (1997) · Science · doi:10.1126/science.277.5326.693 · Cited by 675
Research works printed but not linked: 6
- Maezono, K., Osman, A., Patti, M. E., Cusi, K., Pendergrass, M., DeFronzo, R. A., and Mandarino, L. (1998) Diabetes 47, 333A (abstr.)
- Carboni, J. M., Yan, N., Cox, A. D., Bustelo, X., Graham, S. M., Lynch, M. J., Weinmann, R., Seizinger, B. R., Der, C. J., Barbacid, M., and Manne, V. (1995) Oncogene 10, 1905-1913
- Myers, M. G., Jr., Wang, L. M., Sun, X. J., Zhang, Y., Yenush, L., Schlessinger, J., Pierce, J. H., and White, M. F. (1994) Mol. Cell. Biol. 14, 3577-3587
- Delahaye, L., Mothe-Satney, I., Myers, M. G., Jr., White, M. F., and Van Obberghen, E. (1998) Endocrinology 139, 4911-4919 · DOI · Paper page
- O'Neill, T. J., Craparo, A., and Gustafson, T. A. (1994) Mol. Cell. Biol. 14, 6433-6442
- Chin, J. E., Liu, F., and Roth, R. A. (1994) Mol. Endocrinol. 8, 51-58
Cited by
Items 201–300 of 999
Morino, K., Neschen, S., Bilz, S., Sono, S., Tsirigotis, D., Reznick, R. M., Moore, I., Nagai, Y., Samuel, V., Sebastian, D., et al. (2008) · Diabetes · doi:10.2337/db06-0454 · Cited by 125
Self-citationApoptosis and Cytokines in Non-Alcoholic Steatohepatitis
Syn, W.-K., Choi, S. S., & Diehl, A. M. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.003 · Cited by 125
“JNK activation inhibits the phosphorylation of insulin receptor substrate (IRS)-1 (98,99) while IKKβ activity leads to the activation of NFκB and the induction of additional pro-inflammatory cytokines (100).”
BackgroundBenomar, Y., & Taouis, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00140 · Cited by 144
“JNK promotes the serine phosphorylation of IRS-1 that inhibits insulin-dependent IRS-1 tyrosine phosphorylation and downstream signaling (85, 86).”
BackgroundMolecular pathways disrupted by gestational diabetes mellitus
Nguyen-Ngo, C., Jayabalan, N., Salomon, C., & Lappas, M. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0274 · Cited by 124
Liu, Y.-F., Herschkovitz, A., Boura-Halfon, S., Ronen, D., Paz, K., LeRoith, D., & Zick, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9668-9681.2004 · Cited by 124
“Phosphorylation of S307 is catalyzed by a number of kinases, some of which, like JNK, are activated by insulin (1, 2, 19).”
BackgroundEringa, E. C., Serné, E. H., Meijer, R. I., Schalkwijk, C. G., Houben, A. J. H. M., Stehouwer, C. D. A., Smulders, Y. M., & van Hinsbergh, V. W. M. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9239-7 · Cited by 136
“We have recently shown that PVAT controls insulinstimulated vasodilation in muscle resistance arteries through two antagonistic signaling pathways: a vasodilator pathway mediated by adiponectin and 5′AMP-activated protein kinase (AMPK) and an inflammatory pathway mediated by cjun N-terminal kinase (JNK) [70].”
BackgroundInfluentialImprovement of insulin sensitivity by antagonism of the renin-angiotensin system
Henriksen, E. J. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00147.2007 · Cited by 123
“The protein expression and functionality of IR and IRS-1 can be negatively regulated by serine/threonine phosphorylation (1, 2, 5, 6, 51, 52, 62, 66, 71).”
BackgroundInsulin/IGF-1 and ROS signaling pathway cross-talk in aging and longevity determination
Papaconstantinou, J. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.11.025 · Cited by 122
“Although JNK1 own-regulates insulin sensitivity by phosphorylation of Ser307 in RS-1, decreased JNK1 activity does not increase or prolong tyroine phosphorylation of IRS-1 (Aguirre et al., 2002; Lee et al., 2003; irosumi et al., 2002).”
BackgroundPu, P., Wang, X.-A., Salim, M., Zhu, L., Wang, L., Chen, K.-J., Xiao, J., Deng, W., Shi, H., Jiang, H., et al. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.002 · Cited by 133
An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue
Jaeschke, A., Czech, M. P., & Davis, R. J. (2004) · Genes & Development · doi:10.1101/gad.1216504 · Cited by 121
“JNK can inhibit insulin signaling by phosphorylating the adapter protein insulin receptor substrate 1 (IRS-1) on Ser 307 (Aguirre et al. 2000, 2002; Lee et al. 2003) and is strongly activated by inflammatory cytokines and free fatty acids—molecules that can contribute to the development of type 2…”
BackgroundThe Role of Catechins in Regulating Diabetes: An Update Review
Wen, L., Wu, D., Tan, X., Zhong, M., Xing, J., Li, W., Li, D., & Cao, F. (2022) · Nutrients · doi:10.3390/nu14214681 · Cited by 144
“, serine 307) are phosphorylated by IKK and JNK redox-sensitive kinases [50] (Figure 4).”
BackgroundBose, S. K., Shrivastava, S., Meyer, K., Ray, R. B., & Ray, R. (2012) · Journal of Virology · doi:10.1128/jvi.00050-12 · Cited by 120
“Phosphorylation of Ser/Thr residues of IRS-1 blocks interactions with the insulin receptor, inhibits insulin signal transduction, and may also target IRS-1 for degradation (3, 4).”
BackgroundBashan, N., Dorfman, K., Tarnovscki, T., Harman-Boehm, I., Liberty, I. F., Blüher, M., Ovadia, S., Maymon-Zilberstein, T., Potashnik, R., Stumvoll, M., et al. (2007) · Endocrinology · doi:10.1210/en.2006-1369 · Cited by 121
Inflammatory Mechanisms of Diabetes and Its Vascular Complications
Nedosugova, L. V., Markina, Y. V., Бочкарева, Л. А., Кузина, И. А., Petunina, N. A., Yudina, I. Y., & Kirichenko, T. V. (2022) · Biomedicines · doi:10.3390/biomedicines10051168 · Cited by 156
“Some cytokines, in particular, TNF-α secreted by adipose tissue cells, stimulate the phosphorylation of IRS-1 serine and threonine residues, which reduces IRS-1 tyrosine phosphorylation in response to insulin, as well as the ability of IRS-1 to bind to the insulin receptor, which, in in turn, suppresses signaling [47].”
BackgroundGarcía-Ruiz, C., Baulies, A., Mari, M., García-Rovés, P. M., & Fernandez-Checa, J. C. (2013) · Free Radical Research · doi:10.3109/10715762.2013.830717 · Cited by 119
Han, M. S., Chung, K. W., Cheon, H. G., Rhee, S. D., Yoon, C.-H., Lee, M.-K., Kim, K.-W., & Lee, M.-S. (2009) · Diabetes · doi:10.2337/db08-0080 · Cited by 120
“B: Insulin resistance markers in the liver and adipose tissues of db/db and C57BL/6 mice were studied by Western blotting using antibody to phospho-JNK or phospho-IRS-1 Ser307.”
BackgroundInfluentialRagheb, R., Shanab, G. M. L., Medhat, A. M., Seoudi, D. M., Adeli, K., & Fantus, I. G. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.106 · Cited by 128
“The current finding might carry a substantial interest as a potential therapeutic target for muscle insulin resistance and the treatment of type-2 diabetes [32–34].”
BackgroundImoto, K., Kukidome, D., Nishikawa, T., Matsuhisa, T., Sonoda, K., Fujisawa, K., Yano, M., Motoshima, H., Taguchi, T., Tsuruzoe, K., et al. (2006) · Diabetes · doi:10.2337/db05-1187 · Cited by 118
“At the molecular level, TNF- has consistently been shown to induce the activation of c-jun NH2-terminal kinases (JNKs) (14,15), increase serine phosphorylation of IRS-1, and subsequently decrease insulin-stimulated tyrosine phosphorylation of IRS-1 (14,16).”
BackgroundInsulin resistance in Alzheimer's disease
Diehl, T., Mullins, R., & Kapogiannis, D. (2017) · Translational Research · doi:10.1016/j.trsl.2016.12.005 · Cited by 117
Broussard, S. R., MCCusker, R. H., Novakofski, J. E., Strle, K., Hong Shen, W., Johnson, R. W., Freund, G. G., Dantzer, R., & Kelley, K. W. (2003) · Endocrinology · doi:10.1210/en.2003-0087 · Cited by 114
Fernandez-Twinn, D. S., Alfaradhi, M. Z., Martin-Gronert, M. S., Duque-Guimaraes, D. E., Piekarz, A., Ferland-McCollough, D., Bushell, M., & Ozanne, S. E. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.007 · Cited by 114
“Previous studies have shown that the protein levels of IRS-1 may be regulated by degradation through Ser307 phosphorylation [40].”
BackgroundYang, J., Park, Y., Zhang, H., Xu, X., Laine, G. A., Dellsperger, K. C., & Zhang, C. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01199.2008 · Cited by 114
Taniyama, Y., Hitomi, H., Shah, A., Alexander, R. W., & Griendling, K. K. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000164313.17167.df · Cited by 113
Nasca, C., Dobbin, J., Bigio, B., Watson, K., de Angelis, P., Kautz, M., Cochran, A., Mathé, A. A., Kocsis, J. H., Lee, F. S., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0804-7 · Cited by 113
Physical activity and the endocannabinoid system: an overview
Tantimonaco, M., Ceci, R., Sabatini, S., Catani, M. V., Rossi, A., Gasperi, V., & Maccarrone, M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1575-6 · Cited by 112
“Moreover, AeA has been found to further disturb the insulin pathway, by increasing insulin receptor substrate 1 phosphorylation at Ser307, and thus triggering an inhibitory action [155].”
BackgroundPotashnik, R., Bloch-Damti, A., Bashan, N., & Rudich, A. (2003) · Diabetologia · doi:10.1007/s00125-003-1097-5 · Cited by 120
“Moreover, some [29], (but not all [23]) of the phosphoserine residues might impair insulin receptor-mediated phosphorylation on adjacent tyrosine residues of IRS, resulting in impaired early insulin signalling events.”
BackgroundVallerie, S. N., Furuhashi, M., Fucho, R., & Hotamisligil, G. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003151 · Cited by 111
“One such target is insulin receptor substrate 1 (IRS-1) serine phosphorylation which is mediated by inflammatory kinases such as c-Jun N-terminal kinase (JNK) and IkB kinase beta (IKKb) and consequently modulates insulin action [17–19].”
BackgroundEndoplasmic Reticulum Stress and the Unfolded Protein Response
Kapoor, A., & Sanyal, A. J. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2009.07.004 · Cited by 119
Henstridge, D. C., Whitham, M., & Febbraio, M. A. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.08.003 · Cited by 111
“Finally, JNK serine phosphorylates IRS-1 (ser307) which disrupts IRS-1 and IR interaction, the proximal step in insulin signaling [30,31].”
BackgroundEmanuelli, B., Eberlé, D., Suzuki, R., & Kahn, C. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712275105 · Cited by 110
“This impairs the ability of the insulin receptor to tyrosine phosphorylate IRS-1 and thus reduces its ability to interact with the downstream components of the insulin-signaling network (6).”
BackgroundRole of insulin-like growth factor I signaling in neurodegenerative diseases
Trejo, J. L., Carro, E., Garcia-Galloway, E., & Torres‐Alemán, I. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0499-7 · Cited by 126
“Because IRS contains dozens of potential phosphorylation sites [17], kinase regulation of this docking protein is likely very complex.”
BackgroundLasram, M. M., Dhouib, I. B., Annabi, A. B., Fazâa, S. E., & Gharbi, N. (2014) · Toxicology · doi:10.1016/j.tox.2014.04.009 · Cited by 112
Gogg, S., Smith, U., & Jansson, P.-A. (2009) · Diabetes · doi:10.2337/db08-0961 · Cited by 108
Chen, W., Wang, J., Luo, Y., Wang, T., Li, X., Li, A., Li, J., Liu, K., & Liu, B. (2015) · Journal of Ginseng Research · doi:10.1016/j.jgr.2015.11.002 · Cited by 108
“Pro-inflammatory cytokines, including IL-1b, IL-6, and TNF-a, can impair IRS-1 function by increasing its phosphorylation, thus preventing insulinmediated IRS-1 tyrosine phosphorylation [28].”
BackgroundKang, S., Chemaly, E. R., Hajjar, R. J., & Lebeche, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200022 · Cited by 108
He, J., Usui, I., Ishizuka, K., Kanatani, Y., Hiratani, K., Iwata, M., Bukhari, A., Haruta, T., Sasaoka, T., & Kobayashi, M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0107 · Cited by 108
Tsaousidou, E., Paeger, L., Belgardt, B. F., Pal, M., Wunderlich, C. M., Brönneke, H., Collienne, U., Hampel, B., Wunderlich, F. T., Schmidt-Supprian, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.045 · Cited by 107
Bhuvaneswari, S., & Anuradha, C. V. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-119 · Cited by 107
“Phosphorylation of ser residues of IRS-1 and IRS-2 blocks tyrosine (tyr) phosphorylation by inhibiting the interaction of the adjacent phosphotyrosine (p-Y)-binding domain with the phosphorylated NPEY motif in the activated insulin receptor (Aguirre et al. 2002).”
BackgroundHançer, N. J., Qiu, W., Cherella, C., Li, Y., Copps, K. D., & White, M. F. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554162 · Cited by 107
“Mutational analysis suggests that rodent Ser(P)-307 (Ser(P)-312 in humans) is a principal target of JNK, which appears to disrupt the interaction between the activated insulin receptor and the PTB domain of IRS1 (31, 50).”
BackgroundSelf-citationTeng, W., Zhao, L., Yang, S., Zhang, C., Liu, M., Luo, J., Jin, J., Zhang, M., Bao, C., Li, D., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.023 · Cited by 117
Yan, H., He, L., Lv, D., Yang, J., & Yuan, Z. (2024) · Biomolecules · doi:10.3390/biom14020243 · Cited by 131
“…of IRS1 by JNK inhibits its interaction with insulin receptor (IR), causes defective IRS1 tyrosine phosphorylation, and importantly, abrogates IRS downstream PI3K-AKT signaling, thus promoting FOXO1-mediated gluconeogenesis, and finally causing insulin resistance (Figure 5A) [85–87].”
BackgroundIRS proteins and diabetic complications
Lavin, D. P., White, M. F., & Brazil, D. P. (2016) · Diabetologia · doi:10.1007/s00125-016-4072-7 · Cited by 126
“Aguirre et al originally showed that c-Jun N-terminal kinase (JNK)-induced IRS1 phosphorylation prevents IR–IRS interactions, resulting in impaired insulin signalling [49, 50].”
BackgroundSelf-citationBrain Derived Exosomes Are a Double-Edged Sword in Alzheimer’s Disease
Song, Z., Xu, Y., Deng, W., Zhang, L., Zhu, H., Yu, P., Qu, Y., Zhao, W., Han, Y., & Qin, C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00079 · Cited by 104
“A low tyrosine phosphorylated insulin receptor substrate 1 (IRS1) to serine phosphorylated IRS1 ratio is a characteristic of insulin dysregulation (Aguirre et al., 2002; Draznin, 2006) and is related to greater brain atrophy in AD patients (Mullins et al.”
BackgroundChronic high fat feeding attenuates load‐induced hypertrophy in mice
Sitnick, M., Bodine, S. C., & Rutledge, J. C. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.180174 · Cited by 104
“Many recent studies suggest that the accumulation of triglycerides in muscle with high fat feeding leads to the development of insulin resistance, in part, by interfering with protein phosphorylation along the insulin/IRS-1/PI3-K/Akt signalling pathway (Tremblay & Marette, 2001; Aguirre et al. 2002; Silveira et al. 20…”
BackgroundMonji, A., Mitsui, T., Bando, Y. K., Aoyama, M., Shigeta, T., & Murohara, T. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00990.2012 · Cited by 104
“Left panels; cardiac IRS-1 phosphorylation level 524 of KK mice treated with vehicle (KK-v) and with Ex-4 (KK-ex4).”
BackgroundInfluentialTalbot, N. A., Wheeler-Jones, C. P., & Cleasby, M. E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.010 · Cited by 104
Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
Amemori, T., Jendelova, P., Ruzicka, J., Urdzikova, L., & Sykova, E. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125961 · Cited by 102
“The pro-inflammatory cytokine TNF-α fosters serine phosphorylation of IRS-1 and IRS-2 via JNK binding with IRS proteins, inhibiting subsequent signaling pathways including PI3K/PKB and PI3K/Akt and leading to amyloid deposits and Tau hyperphosphorylation [202,203].”
BackgroundCarnagarin, R., Dharmarajan, A., & Dass, C. R. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.004 · Cited by 123
Andreasen, A. S., Kelly, M., Berg, R. M. G., Møller, K., & Pedersen, B. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023999 · Cited by 102
Mazucanti, C., Cabral-Costa, J., Vasconcelos, A., Andreotti, D., Scavone, C., & Kawamoto, E. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150610125715 · Cited by 102
“Ser312 phosphorylation induces IRS-1 uncoupling [271], leading to its degradation [272], contributing to an insulin response deficiency [273, 274].”
BackgroundInsulin Resistance in the Defense against Obesity
Saltiel, A. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.001 · Cited by 116
Antioxidants: do they have a role in the treatment of insulin resistance?
Evans, J. L. (2007) · PubMed · Cited by 116
Giraud, J., Leshan, R., Lee, Y.-H., & White, M. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308631200 · Cited by 100
Self-citationMalaguarnera, R., Sacco, A., Voci, C., Pandini, G., Vigneri, R., & Belfiore, A. (2012) · Endocrinology · doi:10.1210/en.2011-1843 · Cited by 109
Galic, S., Sachithanandan, N., Kay, T. W., & Steinberg, G. R. (2014) · Biochemical Journal · doi:10.1042/bj20140143 · Cited by 99
The signaling landscape of insulin-like growth factor 1
Khan, M. Z., Zugaza, J. L., & Torres‐Alemán, I. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108047 · Cited by 132
Divergent Roles for IRS-1 and IRS-2 in Breast Cancer Metastasis
Gibson, S. L., Ma, Z., & Shaw, L. M. (2007) · Cell Cycle · doi:10.4161/cc.6.6.3987 · Cited by 107
DEFECTIVE GLUCOSE HOMEOSTASIS DURING INFECTION
McGuinness, O. P. (2005) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.012003.132159 · Cited by 99
Friedman, J. E., Kirwan, J. P., Jing, M., Presley, L., & Catalano, P. M. (2008) · Diabetes · doi:10.2337/db07-1356 · Cited by 98
“Based on the known effects of TNF- to induce serine phosphorylation of both IR and IRS-1, which in turn impairs tyrosine phosphorylation of IRS-1 (40,43), it is possible that the increased TNFexpression in skeletal muscle could lead to the marked impairment in whole-body insulin sensitivity in these obese GDM women.”
BackgroundBazzari, F. H., Abdallah, D. M., & El-Abhar, H. S. (2019) · Molecules · doi:10.3390/molecules24101992 · Cited by 98
“To highlight the intimate cross-talk between AD markers and insulin resistance, earlier findings have illustrated that extracellular accumulation of Aβ oligomers activates an array of kinases to inactivate IRS response by promoting serine phosphorylation, namely Ser312 (in humans) and Ser307 (in rats) [4,37].”
BackgroundGrounds, M. D., Radley, H. G., Gebski, B. L., Bogoyevitch, M. A., & Shavlakadze, T. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2007.04868.x · Cited by 98
“Phosphorylation of the Ser(307) residue leads to dissociation of IRS-1 from the IGF-1 receptor and inhibition of the tyrosine phosphorylation of IRS-1, which is required for the downstream signal transmission from the activated IGF-1 receptor.(61) Use of the JNK inhibitors I-JNK and SP600125 has confirmed the effects…”
BackgroundStressed out about obesity and insulin resistance
de Luca, C., & Olefsky, J. M. (2006) · Nature Medicine · doi:10.1038/nm0106-41 · Cited by 112
Specific protein kinase C isoforms as transducers and modulators of insulin signaling
SAMPSON, S., & COOPER, D. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.04.017 · Cited by 97
“We have recently found that insulin induces phosphorylation of IRS-1 on Ser 307 (Jacob, Zick, Brodie and Sampson-submitted for publication), a suggested site for phosphorylation by PKCs activated by phorbol esters [107,108].”
BackgroundHerschkovitz, A., Liu, Y.-F., Ilan, E., Ronen, D., Boura-Halfon, S., & Zick, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610949200 · Cited by 97
RetractedFructose-mediated stress signaling in the liver: implications for hepatic insulin resistance
Wei, Y., Wang, D., Topczewski, F., & Pagliassotti, M. J. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.03.013 · Cited by 127
“JNK also interferes with proximal steps in the insulin-signaling pathway, in part, through phosphorylation of serine 307 on IRS-1 [80,81].”
BackgroundXia, T., Duan, W., Zhang, Z., Fang, B., Zhang, B., Xu, B., de la Cruz, C. B. V., El-Seedi, H., Simal-Gandara, J., Wang, S., et al. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2020.127513 · Cited by 93
Reversal of Insulin Resistance Postpartum Is Linked to Enhanced Skeletal Muscle Insulin Signaling
Kirwan, J. P., Varastehpour, A., Jing, M., Presley, L., Shao, J., Friedman, J. E., & Catalano, P. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0749 · Cited by 96
Sancheti, H., Akopian, G., Yin, F., Brinton, R. D., Walsh, J. P., & Cadenas, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069830 · Cited by 95
“The serine phosphorylation, and thus the IRS-1 inactivation, is associated with c-Jun NH2-terminal Kinase (JNK) activation [31,32].”
BackgroundThe E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis
Yan, F., Zhang, X., Wang, W., Ji, Y., Wang, P., Yang, Y., Gong, J., Shen, L., Zhu, X., Huang, Z., et al. (2017) · Hepatology · doi:10.1002/hep.28971 · Cited by 95
“JNK increases IRS1 phosphorylation at ser307 and inhibits its tyrosine phosphorylation,((33)) while p38 targets phosphatase and tensin homolog to inhibit phosphoinositide 3-kinase–AKT cascades.”
BackgroundBall, L. E., Berkaw, M. N., & Buse, M. G. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500314-mcp200 · Cited by 94
“5 p307 (38) 323–348, (R)ASSDGEGTMSRPASVDGSPVSPSTNR 2718.”
Dávila, D., & Torres-Aleman, I. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-08-0811 · Cited by 94
Báez, A. M., Ayala, G., Pedroza-Saavedra, A., González-Sánchez, H. M., & Chihu-Amparán, L. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46010041 · Cited by 111
“This introduces the intriguing notion that serine residue phosphorylation may possess a dual functionality, encompassing signal activation [39] or attenuation [21,37] depending on the phosphorylated serine.”
BackgroundJiang, Y., Rose, A. J., Sijmonsma, T. P., Bröer, A., Pfenninger, A., Herzig, S., Schmoll, D., & Bröer, S. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.02.003 · Cited by 94
“Activation of the mTOR pathway results in phosphorylation of several residues of the IRS-1 protein, which can cause insulin resistance [50,51].”
BackgroundMorris, D. L., Cho, K. W., Zhou, Y., & Rui, L. (2009) · Diabetes · doi:10.2337/db08-1388 · Cited by 93
Nie, X., Chen, H., Zhang, J., Zhang, Y., Yang, J., Pan, H., Song, W., Murad, F., He, Y., & Bian, K. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.167 · Cited by 96
Nrf2 Pathway in Age-Related Neurological Disorders: Insights into MicroRNAs
Paladino, S., Conte, A., Caggiano, R., Pierantoni, G. M., & Faraonio, R. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491465 · Cited by 99
Whisenant, T. C., Ho, D. T., Benz, R. W., Rogers, J. S., Kaake, R. M., Gordon, E. A., Huang, L., Baldi, P., & Bardwell, L. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000908 · Cited by 91
“To evaluate the utility of an HMM-based approach for finding novel D-sites, a list of 20 proteins containing functionally verified JNK-docking sites was compiled from our own results and the work of many others [17,18,44,45,46,47,48,49,50,51,52,53,54,55,56] (Fig.”
ResultSárvári, A. K., Veréb, Z., Uray, I. P., Fésüs, L., & Balajthy, Z. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.005 · Cited by 91
“Together, these changes could cause a critical level of inhibition of insulin activity, leading to insulin resistance and metabolic disorders [22–25].”
BackgroundSilvestri, C., Ligresti, A., & Marzo, V. D. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9167-3 · Cited by 92
“, utilizing primary human skeletal muscle cells, AEA at high concentrations (10 μM) was able to induce ERK1/2, p38 and insulin receptor substrate 1 (IRS1[S307]) phosphorylation (which is inhibitory to insulin signalling), as well as inhibit insulin-dependent PKB/Akt phosphorylation and glucose uptake [73, 82].”
MethodLainampetch, J., Panprathip, P., Phosat, C., Chumpathat, N., Prangthip, P., Soonthornworasiri, N., Puduang, S., Wechjakwen, N., & Kwanbunjan, K. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9051929 · Cited by 90
Shen, N., Yu, X., Pan, F., Gao, X., Xue, B., & Li, C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190165 · Cited by 92
The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle
Henriksen, E. J., & Prasannarong, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.011 · Cited by 96
“…ultimately results in defective downstream propagation of the insulin signal and in the development of an insulin-resistant state (Shulman, 2000; Aguirre et al., 2000, 2002; Yu et al., 2002; Potashnik et al., 2003; Bloch-Damti et al., 2006; Henriksen and Teachey, 2007; Archuleta et al., 2009;…”
BackgroundOmega-3 polyunsaturated fatty acids in the brain: metabolism and neuroprotection
Zhang, W. (2011) · Frontiers in Bioscience · doi:10.2741/3878 · Cited by 90
“mediated intracelluar signals by interacting with downstream SH2 domain-containing molecules (115-117).”
BackgroundBiomarkers of Obesity and Subsequent Cardiovascular Events
Musaad, S. M. A., & Haynes, E. N. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm005 · Cited by 117
Modulation of human insulin receptor substrate-1 tyrosine phosphorylation by protein kinase Cdelta
GREENE, M. W., MORRICE, N., GAROFALO, R. S., & ROTH, R. A. (2004) · Biochemical Journal · doi:10.1042/bj20031493 · Cited by 90
Sidarala, V., & Kowluru, A. (2016) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/1872214810666161020154905 · Cited by 105
“Phosphorylation of insulin receptor substrate (IRS-1) at serine-307 by JNK1/2 has been suggested to be detrimental to the interaction of IRS-1 and insulin receptor, thereby blocking insulin signaling [37].”
Danielsson, A., Öst, A., Nystrom, F. H., & Strålfors, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500230200 · Cited by 89
Xu, E., Pereira, M. M. A., Karakasilioti, I., Theurich, S., Al-Maarri, M., Rappl, G., Waisman, A., Wunderlich, F. T., & Brüning, J. C. (2017) · Nature Communications · doi:10.1038/ncomms14803 · Cited by 89
“Activation of c-Jun N-terminal kinase (JNK) in both brain and peripheral metabolic tissues and in immune cells is a major link between chronic tissue inflammation and insulin resistance in obesity 4,43–47 .”
Metabolic characteristics of long-lived mice
Bartke, A., & Westbrook, R. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00288 · Cited by 88
Turdi, S., Ge, W., Hu, N., Bradley, K. M., Wang, X., & Ren, J. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.12.007 · Cited by 88
“On the other hand, IRS-1 dissociation with insulin receptor following Ser phosphorylation of IRS-1 also suppresses PI3K/Akt pathway in obesity [49,50].”
BackgroundOral administration of angiotensin-(1–7) ameliorates type 2 diabetes in rats
Santos, S. H. S., Giani, J. F., Burghi, V., Miquet, J. G., Qadri, F., Braga, J. F., Todiraş, M., Kotnik, K., Alenina, N. V., Dominici, F. P., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1087-0 · Cited by 91
“Phosphorylation of IRS-1 on Ser307 and Ser612 has been implicated in the negative regulation of insulin signaling and may be a main process in the development of insulin resistance [47, 48].”
BackgroundResveratrol and cardiovascular health – Promising therapeutic or hopeless illusion?
Tang, P. C., Ng, Y.-F., Ho, S., Gyda, M., & Chan, S. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.08.001 · Cited by 95
Borujeni, M. J. S., Esfandiary, E., Baradaran, A., Valiani, A., Ghanadian, M., Codoñer‐Franch, P., Basirat, R., Alonso‐Iglesias, E., Mirzaei, H., & Yazdani, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27755 · Cited by 91
“phosphorylate insulin receptor substrate (IRS1) and inactivate insulin receptor (Aguirre et al., 2002).”
BackgroundImpact of Divergent Effects of Astaxanthin on Insulin Signaling in L6 Cells
Ishiki, M., Nishida, Y., Ishibashi, H., Wada, T., Fujisaka, S., Takikawa, A., Urakaze, M., Sasaoka, T., Usui, I., & Tobe, K. (2013) · Endocrinology · doi:10.1210/en.2012-2198 · Cited by 85
“In particular, Ser 307, which is just next to the phosphotyrosine binding (PTB) domain, is phosphorylated by JNK, which decreases insulin-induced tyrosine phosphorylation of IRS-1 (55).”
BackgroundMayer, C. M., & Belsham, D. D. (2010) · Endocrinology · doi:10.1210/en.2009-0838 · Cited by 85
Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes
Schofield, C. J., & Sutherland, C. D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03655.x · Cited by 91
Mitofusin 2 as a Driver That Controls Energy Metabolism and Insulin Signaling
Zorzano, A., Hernández-Alvarez, M. I., Sebastián, D., & Muñoz, J. P. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2014.6208 · Cited by 82
Regulation of β‐cell mass and function by the Akt/protein kinase B signalling pathway
Elghazi, L., Rachdi, L., Weiss, A., CRAS-MÉNEUR, C. M. H., & Bernal‐Mizrachi, E. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00783.x · Cited by 103
Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer mice
Trueba-Sáiz, A., Cavada, C., Fernandez, A. M., Leon, T., González, D. A., Fortea Ormaechea, J., Lleó, A., Del Ser, T., Nuñez, A., & Torres-Aleman, I. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.102 · Cited by 84
Parathyroid hormone suppresses insulin signaling in adipocytes
Chang, E., Donkin, S. S., & Teegarden, D. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.03.024 · Cited by 89
“Phosphorylation of IRS-1 at residue 307 inhibits IR tyrosine kinase activity (Aguirre et al., 2000; Aguirre et al., 2002; Pirola et al., 2004; Sun et al., 1992), which results in insulin resistance in vivo (Ishibashi et al., 2001) and in vitro (Will et al., 2002).”
Background
Metadata
- Authors
- Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F.
- Affiliations
- Joslin Diabetes Center (US)
- Corresponding author
- White, Morris F.
- ORCID
- White, Morris F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-01
- Volume
- 277
- Issue
- 2
- Pages
- 1531-1537
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1972590376
- Cited by
- 1,010
- References
- 55
- Citations by year
- 2026: 27 · 2025: 24 · 2024: 26 · 2023: 25 · 2022: 27 · 2021: 35 · 2020: 30 · 2019: 43 · 2018: 41 · 2017: 33 · 2016: 40 · 2015: 36 · 2014: 57 · 2013: 45 · 2012: 58
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6852 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- IRS-1, insulin resistance, insulin signaling, phosphotyrosine binding domain, insulin receptor, JNK1, MAPK signaling, phosphatidylinositol 3-kinase, protein-protein interaction inhibition
- MeSH terms
- Animals, Anisomycin, Anti-Bacterial Agents, Cell Line, Humans, Insulin, Phosphoproteins, Phosphorylation, Receptor, Insulin, Recombinant Fusion Proteins, Tumor Necrosis Factor-alpha, Signal Transduction, Phosphatidylinositol 3-Kinases, Two-Hybrid System Techniques, Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 8, Rats, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.